Question

A 48-year-old man with type 2 diabetes on maximal tolerated Metformin has an HbA1c of 75 mmol/mol. He has established cardiovascular disease and an eGFR of 50 mL/min/1.73 m². What is the most appropriate additional agent to improve glycaemic control and reduce cardiovascular risk?

Accepted Answer

Add an SGLT2 inhibitor

Answer

Add a Sulfonylurea

Answer

Add a DPP-4 inhibitor

Answer

Add a Thiazolidinedione

Answer

Switch to insulin monotherapy

Practice question

A 48-year-old man with type 2 diabetes on maximal tolerated Metformin has an HbA1c of 75 mmol/mol. He has established cardiovascular disease and an eGFR of 50 mL/min/1.73 m². What is the most appropriate additional agent to improve glycaemic control and reduce cardiovascular risk?